Post-approval studies (Phase 4)Ended earlyNCT01283971
What this trial is testing
RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor
Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 96